Communicating Data and Analytical Findings Questions

Direct answer

A p-value is the probability of seeing a result at least this extreme if there were truly no effect at all. It is NOT the probability that your finding is wrong, and it is not the size of the effect; a tiny, meaningless effect can still produce a small p-value with enough data.

Structured elaboration

The most useful analogy: imagine flipping a coin you believe is fair. If you flip it 10 times and get 9 heads, that's surprising if the coin is really fair, a low "p-value" moment. The p-value quantifies exactly that surprise: assuming there's genuinely no effect, how unlikely is data this extreme? A common threshold like 0.05 means "if there were truly no effect, we'd see a result this strong or stronger only 5% of the time by chance."
Two misinterpretations to correct explicitly:

• "The p-value is the probability our result is a fluke" - wrong; it's the probability of the DATA given no effect, not the probability of no effect given the data.
• "A significant p-value means the effect is important" - wrong; with a large enough sample, even a trivially small effect will produce a very low p-value.

Worked example

Avoid saying: "The p-value was 0.03, so there's a 97% chance our change caused the improvement."
Say instead: "If our change actually did nothing, we'd see an improvement this large or larger only about 3% of the time by chance. That makes chance an unlikely explanation, though it doesn't tell us how big the real effect is or whether it's worth the cost of a full rollout."

Trade-offs and pitfalls

The p-value should influence a decision alongside effect size and business cost, never alone: a statistically solid but tiny effect may not justify the engineering cost of shipping it, while a promising but not-yet-significant effect on a high-stakes decision may be worth more data before acting. Presenting a p-value in isolation, without effect size and a stated decision threshold, invites the audience to treat "significant" as a synonym for "important," which it is not.

Direct answer

Score every candidate insight on the same short rubric before you write a single slide: business impact, confidence in the finding, and alignment with what leadership is already deciding this quarter. Insights that score high on all three make the cut; everything else goes to the appendix, however interesting it is.

Structured elaboration

A repeatable distillation process looks like this:

1. Long-list everything. Pull every finding, even ones you're not proud of, into a flat list.
2. Score three axes, 1-3 each. Impact (how much money or risk it touches), confidence (how solid the evidence is), and strategic alignment (does it inform a decision leadership is actually making now).
3. Take the top 3-4 by summed score, breaking ties in favor of higher confidence over higher impact - a huge, shaky number will get picked apart in the room and cost you more credibility than a smaller, solid one.
4. Check for overlap. Two insights that support the same recommendation should usually be merged into one, stronger slide.
5. Write the headline for each BEFORE the supporting detail, so you can tell immediately whether an insight survives the "so what" test.

Worked example

Say a rubric run over 12 candidate KPI-level insights from a quarterly review scores:

• "Checkout latency regressed 15%" -> impact 2, confidence 3, alignment 3 -> 8
• "New-user activation dipped in one region" -> impact 2, confidence 2, alignment 1 -> 5
• "Support ticket volume up 20% after a UI change" -> impact 3, confidence 3, alignment 2 -> 8
• "A minor copy change increased click-through 0.3%" -> impact 1, confidence 2, alignment 1 -> 4
  The two 8s and one more high-scoring item become the leadership review; the 0.3%-click-through finding, however real, does not make the cut because it does not touch a decision leadership is making this quarter.

Trade-offs and pitfalls

The temptation is to keep an insight because it was hard-won or because a stakeholder mentioned it once; the rubric exists precisely to override that instinct. Watch for two failure modes: keeping a high-impact but low-confidence finding because it is the most dramatic (it will not survive scrutiny and burns credibility for the next review), and dropping a genuinely important finding because it is unglamorous (a shrinking-margin trend rarely excites a room, but it may be the most consequential item on the list). When two findings compete for the same slide, resolve it by testing whether the SAME recommendation follows from both; if so, merge them and cite both as evidence.

Direct answer

The strongest version of this story names the specific choice you made to adapt to the audience, not just that you "simplified" - for example, replacing a statistical test name with what it protects the business from, or leading with the recommendation before the method. The result should include what changed because of the presentation, not just that it went well.

Structured elaboration

A STAR answer for this prompt should cover:

• Situation: what was being analyzed and who the audience was, including their technical background.
• Task: what you needed them to understand or decide.
• Action - the specific simplification: name the ONE technique you used (an analogy, a recommendation-first restructure, dropping a term of art and replacing it with its business consequence) rather than a vague "I made it simpler."
• Result: what decision or action followed, and ideally a way you confirmed they actually understood (a question they asked back, a decision they made that matched the finding).
  When the story also needs to cover handling skeptical follow-up, aligning technical metrics to business KPIs, or measuring impact after the fact, fold those in as a natural extension of the Result section rather than a separate story.

Worked example

"I was presenting a churn model's output to a VP of Customer Success who had no data background (Situation). She needed to decide whether to fund a proactive outreach team based on the model's predictions (Task). Instead of describing precision and recall, I reframed it as 'of the 100 customers the model flags each week, about 40 will actually churn without intervention, and reaching out to all 100 catches most of the real churners at the cost of some wasted outreach' (Action - the specific simplification, tying a model metric directly to a business KPI: outreach cost per retained customer). She asked one clarifying question, whether the 40-in-100 rate was stable month to month, which told me the reframing had landed. She approved a pilot outreach team sized to that ratio, and three months later we measured a 12% reduction in churn among the flagged cohort (Result)."

Trade-offs and pitfalls

A weak version of this answer stays abstract ("I used simple language and it went well"); an interviewer will probe for the SPECIFIC choice, so have one ready. A second common gap is skipping the Result's verification step: saying the audience "understood" is a claim, but a clarifying question they asked or a decision they made that matches the finding is evidence. If you're also asked to show you handled skepticism or measured impact later, don't bolt on a second unrelated anecdote; extend the same story so the Result section carries both the immediate decision and the longer-term measured outcome.

Direct answer

A p=0.04 result from a small, marginal-effect experiment technically clears the conventional significance bar, but small samples make that bar less trustworthy than it looks, so the honest read pairs the p-value with an explicit caveat about sample size before recommending anything.

Structured elaboration

What the p-value means here, in plain terms: "if there were truly no effect, a result this strong or stronger would happen about 4% of the time by chance, so it's more likely there's a real effect than not." The caveat: with a small sample, effect-size ESTIMATES are noisy even when the p-value crosses the threshold, meaning the true effect could be considerably smaller (or occasionally larger) than what was observed; a "just barely significant" result from a small sample is more fragile than the same p-value from a large one. Practical significance is a second, separate question: even if real, is the marginal effect size big enough to be worth acting on at all.
Recommended next steps: treat this as a promising signal rather than a settled result, and prioritize either running a larger follow-up test or extending the current one, rather than shipping immediately on a small-sample, marginal result.

Worked example

"We saw a real effect here, p=0.04, but the sample was small and the effect itself was marginal, maybe a 1% lift. With a small sample, that 1% estimate could plausibly be anywhere from 0.2% to 3% in reality, we just don't have enough data yet to pin it down tightly. Given both the small sample and the modest size, I'd recommend running a larger follow-up before committing engineering resources to a full rollout."

Trade-offs and pitfalls

The risk of treating a small-sample p<0.05 result as conclusive is exactly the scenario that erodes trust later, if a "significant" result from a small test doesn't replicate at scale, stakeholders reasonably start discounting future significance claims too. Naming the small-sample caveat up front, even when it complicates an otherwise clean-sounding result, protects the credibility of every future result you present.

Direct answer

A dual-axis line chart plotting two unrelated metrics (say, model accuracy and unrelated revenue) is a chart to avoid, since lining up two independent y-axes visually implies a relationship between the series that may not exist at all; a clearer alternative is two separate small charts, or one chart with a single shared, meaningful axis.

Structured elaboration

The problem with dual-axis charts specifically: the two axes' scales are chosen somewhat arbitrarily (often just to make both lines fit nicely on the same plot), so whether the lines appear to move together or apart is an artifact of that scaling choice, not a fact about the data. A viewer has no way to tell, just by looking, whether the visual correlation is real or an accident of how the axes were stretched.
A clearer alternative for showing two related metrics, like model accuracy and business KPI over time, is either two small charts stacked vertically sharing the same x-axis (time), so the reader can compare timing of movements without a misleading implied scale relationship, or, if a single relationship IS the point, a scatter plot of one metric against the other with time encoded as color, which shows the actual relationship rather than an axis-scaling illusion.

Worked example

A slide shows model AUC (left axis, 0.70-0.80) and weekly revenue (right axis, $80k-$120k) as two lines that appear to move in lockstep. Rescaled independently (revenue axis stretched or compressed), the same two lines could be made to look correlated or uncorrelated at will, which is exactly why the chart is misleading regardless of which version happens to be shown. Two stacked charts, AUC over time on top and revenue over time below, sharing only the x-axis, let a viewer judge for themselves whether the timing lines up, without the artificial visual pull of a dual y-axis.

Trade-offs and pitfalls

The dual-axis chart is seductive precisely because it looks efficient, one chart instead of two, and can look impressively "connected." The cost is that it invites exactly the kind of correlation-implies-causation reasoning that a careful analyst should be actively working against elsewhere in the same presentation. When a real relationship between two metrics needs to be shown, prefer a chart type where the relationship is a direct visual encoding, like a scatter plot, rather than an artifact of two independently-chosen scales.